TrialAmerican journal of hematology2017
Losartan for the nephropathy of sickle cell anemia: A phase-2, multicenter trial.
Charles T Quinn et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this paperpooled ittrialcites it